Videos

nders Gilberg, MGA, senior vice president, government affairs at Medical Group Management Association (MGMA), shares concerns about the draft fee schedule published in July. Congress was poised to reverse part of the cut in physician pay last December, but Elon Musk intervened and no fix was made. Congress instead made promises to help in 2026, but MGMA says it is not enough.

MGMA raises alarm over 2026 Medicare Physician Fee Schedule, warns of access crisis

Many make federal reimbursement plans into an issue about high-paid specialists complaining about pay cuts, but these fees also compensate nurses, technicians, support staff and administrators. Payment keeps the doors of brick-and-mortar medical practices open, MGMA warns.

Geoffrey Rose, MD, president of Sanger Heart and Vascular Institute, discusses how to manage a sustainable cardiology practice in the coming decade and what challenges are involved.

Cardiology practices must be more sustainable to survive

Cardiology faces one of its most challenging decades ahead, with mounting pressures from workforce shortages, an aging population and declining reimbursements. To remain sustainable, practices are forced to rethink how care is delivered from the ground up.

 Greg Piefer, PhD, CEO and founder of Shine, explains the timeline to restart U.S. production of molybdenum-99 (Mo-99) for nuclear imaging.

Shine working toward U.S. production of Mo-99 for SPECT nuclear imaging

Greg Piefer, PhD, chief executive and founder of Shine, a Wisconsin-based radiopharmaceutical company that is building the world’s largest medical isotope production facility in Janesville, Wisconsin, explains progress on the company's fusion reactor that will become the first sustained U.S. commercial supplier of molybdenum-99 in decades.

Kenzie Thompson, BSN, RCIS, cardiovascular invasive specialist, St. Luke's Mid-America Heart Institute, shares advice she gave to cath lab technologists and nurses during a session at the Transcatheter Cardiovascular Therapeutics (TCT) meeting.

How to prepare for cath lab complications

“It is your responsibility to be the patient’s advocate,” one expert explained. “We, as the nurses and technologists, have to speak up when we see something that isn’t right.”

Molecular Imaging PET and SPECT sign in GE booth ACC23.

Shine working toward U.S. production of Mo-99 for SPECT imaging

Greg Piefer, PhD, chief executive and founder of SHINE, a Wisconsin-based radiopharmaceutical company that is building the world’s largest medical isotope production facility in Janesville, Wisconsin, explains progress on the company's fusion reactor that will become the first U.S. commercial supplier of molybdenum-99 in decades.

Anders Gilberg, MGA, senior vice president, government affairs at Medical Group Management Association (MGMA), shares concerns about the draft fee schedule published in July. A major concern is the government possibly changing how relative value units (RVUs) are set, rather than allowing the American Medical Association and medical speciality representatives having a say. #MGMA

MGMA warns of government overreach in the proposed 2026 Medicare Physician Fee Schedule

The Medical Group Management Association shares concerns about the draft fee schedule published in July. A major concern is the government possibly changing how RVUs are set, rather than allowing the medical specialty representatives to have a say.

Seth Baum, MD, FACC, FACPM, FAHA, FNLA, FASPC, Chairman of the Board for the Family Heart Foundation, past president of the American Society for Preventive Cardiology, clinical affiliate professor of biomedical science at Florida Atlantic University, and chief medical officer of Flourish Research, explains why testing for familial hypercholesterolemia (FH) and elevated Lipoprotein(a) could be critical to identify more patients with elevated risk of cardiac events, but have their LDL well controlled.

Lipoprotein(a) tests could transform patient care—is it time for universal screening?

"Lp(a) represents the most important potential potential paradigm shift in cardiovascular disease prevention that we'll experience over the next five to 10 years," Seth Baum, MD, explained in a new interview.

Video interview with Jaffar Khan, MD, St. Francis Heart Center, explaining tests using IVL in mitral annular calcification (MAC).

Can IVL help cardiologists treat mitral valve disease?

Jaffar Khan, MD, explained his team's work using intravascular lithotripsy balloons in a cadaver heart to break up mitral annular calcification.